Organization Profile

You just read:

Quest PharmaTech Acquires Immunoglobulin E Technology to Strengthen its Combination Therapy Approach for the Treatment of Cancer

News provided by

Quest PharmaTech Inc.

Oct 02, 2012, 09:30 ET